Cure8 news brief
Postoperative endoscopic recurrence after ileocolic resection is an important risk for people with Crohn’s disease; this study links HNBT and possibly e-cigarette use to higher recurrence rates, which could affect monitoring and preventive care after surgery.
Adults with Crohn’s disease who are current smokers, heat-not-burn tobacco users, or e-cigarette users; clinicians who manage postoperative Crohn’s care; caregivers of post-surgery patients.
This HealthDay report summarizes a retrospective study in the American Journal of Gastroenterology that evaluated postoperative endoscopic recurrence of Crohn’s disease after ileocolic resection.
Researchers classified patients as nonsmokers, cigarette smokers, heat-not-burn tobacco (HNBT) users, or e-cigarette users and compared endoscopic recurrence (Rutgeerts score ≥2) at one year.
The study found higher recurrence rates in all smoking groups versus nonsmokers; HNBT use remained significantly associated with recurrence in multivariable analysis while the e-cigarette association did not reach statistical significance.
Interpretation and practical points The authors suggest managing patients who use HNBT or e-cigarettes similarly to traditional smokers in the postoperative setting because of the observed higher recurrence rates.
The analysis included fecal calprotectin and modified Rutgeerts cutoffs and reported associations even among patients receiving pharmacologic prophylaxis. If you use HNBT or e-cigarettes Talk with your GI team about your tobacco or nicotine product use before and after surgery so they can consider it when planning postoperative monitoring and prophylaxis.
Endoscopic surveillance and fecal calprotectin were used in the study to detect recurrence; your clinician may recommend a similar approach based on your individual risk.
This is a retrospective observational study, so it shows association but not proof of causation. The e-cigarette association did not reach statistical significance in multivariable analysis, while HNBT did. Management recommendations are based on the study authors’ suggestions, not on guideline changes. Summary grounded in the HealthDay report of the published study.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
After bowel resection, Crohn’s often returns quietly at the surgical join (anastomosis). Early, planned monitoring can detect inflammation before symptoms appear and help prevent symptomatic recurrence or repeat surgery.
Noninvasive tests at 3 months after ileocecal resection (ultrasound + fecal calprotectin) may identify patients at high risk of endoscopic recurrence by 6 months. That could help avoid or target postoperative endoscopy...
The study tests whether adding MRI-based transmural assessment to a fecal-calprotectin–guided (CALM) strategy improves the ability to keep people with Crohn’s disease in corticosteroid-free clinical remission and may...
